Table 2 Duration of sustained activation of each muscle comparison (ms).
Muscle | Injury group | Control group | p-valuea | ||
|---|---|---|---|---|---|
Dominant leg (Affected limb) | Non-dominant leg (Healthy limbs) | Dominant leg | Non-dominant leg | ||
VL | 354.12 ± 101.82 | 339.37 ± 84.57 | 337.64 ± 87.35 | 329.28 ± 105.18 | 0.8781 |
VM | 336.45 ± 77.18 | 322.16 ± 80.08 | 311.22 ± 82.60 | 321.59 ± 86.27 | 0.4906 |
BF | 346.61 ± 73.52 | 335.16 ± 65.84 | 305.52 ± 55.67* | 315.43 ± 59.81 | 0.4472 |
ST | 347.34 ± 66.86 | 338.24 ± 65.05 | 311.34 ± 57.10 | 319.97 ± 54.78 | 0.5084 |
Gmax | 261.39 ± 52.60 | 257.49 ± 49.75 | 230.04 ± 42.81* | 235.21 ± 55.30 | 0.6808 |